Results 51 to 60 of about 429 (97)

Novel biomarkers with promising benefits for diagnosis of cervical neoplasia: a systematic review. [PDF]

Infect Agent Cancer, 2020
Onyango CG, Ogonda L, Guyah B, Shiluli C, Ganda G, Orang'o OE, Patel K.   +6 more
europepmc   +1 more source

Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to Cytology: A Population-Based Study of HPV DNA-Positive Women. [PDF]

Pathogens
Sørbye S, Falang BM, Antonsen M, Mortensen E.   +3 more
europepmc   +1 more source

The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma. [PDF]

Rom J Morphol Embryol
Voidăzan TS, Budianu MA, Cotoi OS, Turdean SG.   +3 more
europepmc   +1 more source

A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups. [PDF]

Int J Cancer, 2022
Clarke MA, Deshmukh AA, Suk R, Roberts J, Gilson R, Jay N, Stier EA, Wentzensen N.   +7 more
europepmc   +1 more source

Molecular Screening for Cervical Cancer. [PDF]

Genes (Basel)
Martins TR, Levi JE.
europepmc   +1 more source

Barriers to cervical cancer prevention and triage strategies: a study of knowledge, attitudes, and p16/Ki-67 dual-staining utility among high-risk women in Tuoli and Fuyun counties, Xinjiang. [PDF]

PeerJ
Tali H, Yeerjiang K, Zeng BB, Rui T, Musha B, Wang Y.   +5 more
europepmc   +1 more source

Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus. [PDF]

J Low Genit Tract Dis
Clarke MA, Wentzensen N, Perkins RB, Garcia F, Arrindell D, Chelmow D, Cheung LC, Darragh TM, Egemen D, Guido R, Huh W, Locke A, Lorey TS, Nayar R, Risley C, Saslow D, Smith RA, Unger ER, Massad LS, Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.   +19 more
europepmc   +1 more source

Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review. [PDF]

Diagnostics (Basel)
Gisca T, Matasariu DR, Ursache A, Socolov DG, Scripcariu IS, Fudulu A, Anton ET, Botezatu A.   +7 more
europepmc   +1 more source

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC. [PDF]

Future Oncol
Siu LL, Burtness B, Harrington K, Psyrri A, Saba NF, Tahara M, Carlson G, Dhar A, Grimshaw M, Hua L, Iadevaia R, Theti D, Vlahovic G, Machiels JP.   +13 more
europepmc   +1 more source

Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial. [PDF]

Nat Commun
Ju H, Wu Y, Shi C, Xia R, Song H, Ma X, Liu Y, Sun L, Zhu L, Chen L, Sun S, He Y, Ren G, Hu J.   +13 more
europepmc   +1 more source